Skip to content
  • Français
  • English
Seabelife
  • Home
  • News
  • Indications
  • Technology
  • Team
  • Scientific Publications
  • Contact
  • FR
Seabelife
  • Home
  • News
  • Indications
  • Technology
  • Team
  • Scientific Publications
  • Contact
  • FR

SeaBeLife receives close to €1.4M deep tech financing from Bpifrance

16 March 202216 March 2022

Funds will enable SeaBeLife to develop pipeline of innovative molecules intended to block programmed cell death in cases of acute … Lire la suite

Categories Press Release

SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death

28 May 2021

SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death. Roscoff, May 17th, 2021. SeaBeLife, … Lire la suite

Categories Press Release

SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death.

9 February 202119 June 2020

SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death. Roscoff, June 15, 2020. SeaBeLife, a pharmaceutical … Lire la suite

Categories Press Release

Categories

  • Press Release (3)

Recent Posts

  • SeaBeLife receives close to €1.4M deep tech financing from Bpifrance
  • SeaBeLife Biotech raises € 1 million to carry onits drug developments targeting regulated cell death
  • SeaBeLife Biotech raises € 1.5 million to develop drugs targeting regulated cell death.

A biotech company developing a range of drugs designed to block cell necrosis to treat serious diseases affecting major organs, without therapeutic alternatives

  • Contact
  • Recrutement
  • FrançaisFrançais

legals

© SeaBeLife - 2023